On computer‐intensive simulation and estimation methods for rare‐event analysis in epidemic models

This article focuses, in the context of epidemic models, on rare events that may possibly correspond to crisis situations from the perspective of public health. In general, no close analytic form for their occurrence probabilities is available, and crude Monte Carlo procedures fail. We show how recent intensive computer simulation techniques, such as interacting branching particle methods, can be used for estimation purposes, as well as for generating model paths that correspond to realizations of such events. Applications of these simulation-based methods to several epidemic models fitted from real datasets are also considered and discussed thoroughly.

[1]  Nando de Freitas,et al.  Sequential Monte Carlo Methods in Practice , 2001, Statistics for Engineering and Information Science.

[2]  Paul Glasserman,et al.  Multilevel Splitting for Estimating Rare Event Probabilities , 1999, Oper. Res..

[3]  Alexander Grey,et al.  The Mathematical Theory of Infectious Diseases and Its Applications , 1977 .

[4]  Viet Chi Tran,et al.  HIV with contact tracing: a case study in approximate Bayesian computation. , 2008, Biostatistics.

[5]  J. Desenclos,et al.  [Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]. , 2005, Revue d'epidemiologie et de sante publique.

[6]  E. Volz SIR dynamics in random networks with heterogeneous connectivity , 2007, Journal of mathematical biology.

[7]  Pieter-Tjerk de Boer,et al.  Techniques for simulating difficutl queueing problems: adaptive importance sampling simulation of queueing networks , 2000, WSC '00.

[8]  Gerardo Rubino,et al.  Introduction to Rare Event Simulation , 2009, Rare Event Simulation using Monte Carlo Methods.

[9]  F. Cérou,et al.  Adaptive Multilevel Splitting for Rare Event Analysis , 2007 .

[10]  F. Gland,et al.  Genetic genealogical models in rare event analysis , 2006 .

[11]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .

[12]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[13]  Stéphan Clémençon,et al.  The HIV/AIDS epidemic in Cuba: description and tentative explanation of its low HIV prevalence , 2007, BMC infectious diseases.

[14]  Reuven Y. Rubinstein,et al.  Optimization of computer simulation models with rare events , 1997 .

[15]  Valerie Isham,et al.  Stochastic Models for Epidemics with Special Reference to AIDS , 1993 .

[16]  Thomas Berg,et al.  ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. , 2014, The New England journal of medicine.

[17]  A. Lok,et al.  Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. , 2014, The New England journal of medicine.

[18]  D. Vere-Jones Markov Chains , 1972, Nature.

[19]  Paul Dupuis,et al.  The design and analysis of a generalized RESTART/DPR algorithm for rare event simulation , 2011, Ann. Oper. Res..

[20]  P. Moral Feynman-Kac Formulae: Genealogical and Interacting Particle Systems with Applications , 2004 .

[21]  Shie Mannor,et al.  A Tutorial on the Cross-Entropy Method , 2005, Ann. Oper. Res..

[22]  M. S. Bartlett,et al.  Some Evolutionary Stochastic Processes , 1949 .

[23]  Agnès Lagnoux,et al.  RARE EVENT SIMULATION , 2005, Probability in the Engineering and Informational Sciences.

[24]  Peter W. Glynn,et al.  Stochastic Simulation: Algorithms and Analysis , 2007 .

[25]  Albert D Donnenberg,et al.  Rare-event analysis in flow cytometry. , 2007, Clinics in laboratory medicine.

[26]  Stéphan Clémençon,et al.  A stochastic SIR model with contact-tracing: large population limits and statistical inference , 2008, Journal of biological dynamics.

[27]  John McNally,et al.  Sofosbuvir for previously untreated chronic hepatitis C infection. , 2013, The New England journal of medicine.

[28]  P. Moral,et al.  Branching and interacting particle systems. Approximations of Feynman-Kac formulae with applications to non-linear filtering , 2000 .

[29]  Philippe Picard,et al.  A non-standard family of polynomials and the final size distribution of Reed-Frost epidemic processes , 1990, Advances in Applied Probability.

[30]  Joseph Gani,et al.  Stochastic Epidemic Models and Their Statistical Analysis , 2002 .

[31]  G. Dore,et al.  Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  Charles J. Mode,et al.  Stochastic Processes in Epidemiology: Hiv/Aids, Other Infectious Diseases and Computers , 2000 .

[33]  L. Decreusefond,et al.  Large graph limit for an SIR process in random network with heterogeneous connectivity , 2010, 1007.3958.

[34]  Robert Herring,et al.  Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. , 2014, The New England journal of medicine.

[35]  G. Roberts,et al.  Bayesian inference for partially observed stochastic epidemics , 1999 .

[36]  James A. Bucklew,et al.  Introduction to Rare Event Simulation , 2010 .

[37]  Stefan Zeuzem,et al.  Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. , 2014, The New England journal of medicine.

[38]  P. Moral,et al.  Genealogical particle analysis of rare events , 2005, math/0602525.

[39]  Stefano Giordano,et al.  Rare event simulation , 2002, Eur. Trans. Telecommun..

[40]  W. Dowdle The principles of disease elimination and eradication. , 1998, Bulletin of the World Health Organization.

[41]  Vivek S. Borkar,et al.  Adaptive Importance Sampling Technique for Markov Chains Using Stochastic Approximation , 2006, Oper. Res..